Shanghai Hansundi Life Sciences Invited to Attend the 7th Future Healthcare 100 Summit 2023

Over the past decade, the global healthcare industry has undergone significant restructuring, a transformation accelerated by the COVID-19 pandemic since 2020. Having withstood the compounded challenges of global upheaval and the century-defining pandemic from 2020 to 2022, 2023 marked the first year for implementing the strategic directives laid out at the 20th National Congress of the Communist Party of China, as well as a critical year for advancing the 14th Five-Year Plan. Only by accumulating strength, demonstrating the resilience to “remain steadfast despite countless trials,” and embodying the spirit to “press forward all the more in the face of adversity,” can innovators in the healthcare sector bolster their confidence through decisive action and successfully deliver on the era’s mandate for high-quality development in healthcare.

Life sciences have become the most prominent annual hotspot, drawing significant attention from both industry and capital markets. This time,HanZanDi at the Smart Laboratory Forum of the Future Healthcare Top 100 ConferenceCEO Ms. Gloria LiWill attend and participate in the roundtable discussion,Mr. Zhang Siyuan, CTOwill deliver a presentation on the theme of "The Implementation Pathway of HanZandi Smart Laboratory" at the forum, Hanzandi is committed to becomingThe Pioneer in Intelligent End-to-End Life Science SolutionsAt this conference, we look forward to exchanging insights with experts and scholars on the technological iteration and innovation of smart laboratories, exploring the future direction of the industry, and making smart laboratories an accelerator for the rapid development of the life sciences and biopharmaceutical sectors.